The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals

Neoplasma

Volumn 55, Issue 6, 2008, Pages 549-554

  Perhavec, A ^a   Cerkovnik, P ^a   Novakovic, S ^a   Zgajnar, J ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Breast cancer; Breast surgery; hTERT mRNA; Telomerase

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; PROTEIN SUBUNIT; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RNA ISOLATION; BLOOD; BREAST TUMOR; COMPARATIVE STUDY; GENETICS; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN SUBUNITS; RNA, MESSENGER; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 59749093383     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. MEEKER AK, ARGANI P. Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia 2004; 9: 285-296.
2. BUERGER H, OTTERBACH F, SIMON R et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402.
3. MOORE E, MAGEE H, COYNE J et al.: Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS. J Pathol 1999; 187: 403-409.
4. WALDMAN FM, DEVRIES S, CHEW KL et al.: Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000; 92: 313-320.
5. CHEUNG AL, DENG W. Telomere dysfunction, genome instability and cancer. Front Biosci 2008; 13: 2075-2090.
6. FENG J, FUNK WD, WANG SS et al. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
7. NAKAMURA TM, MORIN GB, CHAPMAN KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-959.
8. BLASCO MA. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2: 627-633.
9. HIYAMA K, HIRAI Y, KYOIZUMI S et al.: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
10. KYO S, NAKAMURA M, KIYONO T et al. Successful immortalization of endometrial glandular cells with normal structural and functional characteristics. Am J Pathol 2003; 163: 2259-2269.
11. RAMIREZ RD, WRIGHT WE, SHAY JW et al. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 1997; 108: 113-117.
12. KYO S, INOUE M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 2002; 21: 688-697.
13. SHAY JW, BACCHETTI S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791. (Pubitemid 27239490)
14. CAREY LA, HEDICAN CA, HENDERSON GS, et al. Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers. Clin Cancer Res 1998; 4: 435-440.
15. HIYAMA E, GOLLAHON L, KATAOKA T et al.: Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116-122. (Pubitemid 26020100)
16. MOKBEL K, PARRIS CN, GHILCHIK M et al. The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg 1999; 178: 69-72. (Pubitemid 29375068)
17. PEARSON AS, GOLLAHON LS, O'NEAL NC et al. Detection of telomerase activity in breast masses by fine-needle aspiration. Ann Surg Oncol 1998; 5: 186-193.
18. SUGINO T, YOSHIDA K, BOLODEOKU J et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 1996; 69: 301-306.
19. POREMBA C, HEINE B, DIALLO R et al. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 2002; 198: 181-189.
20. LLEDO SM, GARCIA-GRANERO E, DASI F et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis 2004; 6: 236-242.
21. CHEN XQ, BONNEFOI H, PELTE MF et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6: 3823-3826. (Pubitemid 30807069)
22. DASI F, LLEDO S, GARCIA-GRANERO E et al. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab Invest 2001; 81: 767-769.
23. KOPRESKI MS, BENKO FA, KWAK LW, GOCKE CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999; 5: 1961-1965. (Pubitemid 29399244)
24. KOPRESKI MS, BENKO FA, GOCKE CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 2001; 945: 172-178.
25. NOVAKOVIC S, HOCEVAR M, ZGAJNAR J et al. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol Rep 2004; 11: 245-252.
26. PELOSI G, SCHIANCHI E, DELL'ORTO P et al. Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. Virchows Arch 2006; 448: 7-15.
27. CERKOVNIK P, PERHAVEC A, ZGAJNAR J et al.S: Optimization of an RNA isolation procedure from plasma samples. Int J Mol Med 2007; 20: 293-300.
28. HU XC, LOO WT, CHOW LW. Surgery-related shedding of breast cancer cells as determined by RT-PCR assay. J Surg Oncol 2003; 82: 228-232. (Pubitemid 36389914)